Epigenic Therapeutics

EPIGENIC

Shanghai, China · Founded 2021 · $80.0M raised

Headquarters
Shanghai
Founded
2021
Business Model
B2B
Total Funding
$80.0M
Last Round
$20.0M Series AFeb 2025
Rounds
3

About

Epigenic Therapeutics is a Shanghai-based frontier biotechnology company founded in 2021 by leading scientists to develop next-generation epigenetic engineering therapies. Its proprietary EPIREG platform uses AI-driven algorithms combined with patented CRISPR-Cas components and lipid nanoparticle delivery technology to regulate gene expression without altering the DNA sequence, targeting metabolic, cardiovascular, viral hepatitis, ocular, oncology, and rare disease indications.

Summary

Epigenic Therapeutics is a Biotech company based in Shanghai, China, founded in 2021. It has raised $80.0M in total across 3 rounds, most recently a $20.0M Series A round in Feb 2025. Investors include Qiming VP, OrbiMed and Morningside Group.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BFeb 2025
$60.0M

Sign up to see all 3 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Epigenic Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/epigenic-therapeutics"><img src="https://indexed.vc/api/badge/company/epigenic-therapeutics" alt="Epigenic Therapeutics on Indexed.vc" width="260" height="76" /></a>